Mesenchymal stem cells in the treatment of ischemic stroke

• Published in: Kliničeskaâ praktika Vol. 14; no. 4; pp. 49 - 64
• Main Authors: Namestnikova, Daria D., Kovalenko, Daria B., Pokusaeva, Irina A., Chudakova, Daria A., Gubskiy, Ilya L., Yarygin, Konstantin N., Baklaushev, Vladimir P.
• Format: Journal Article
• Language: English
• Published: Eco-vector 28.01.2024
• Subjects: cell therapy; clinical trials; ischemic stroke; mesenchymal stem cells
• ISSN: 2220-3095; 2618-8627
• DOI: 10.17816/clinpract624157

Over the past two decades, multiple preclinical studies have shown that transplantation of mesenchymal stem cells leads to a pronounced positive effect in animals with experimental stroke. Based on the promising results of preclinical studies, several clinical trials on the transplantation of mesenchymal stem cells to stroke patients have also been conducted. In this review, we present and analyze the results of completed clinical trials dedicated to the mesenchymal stem cells transplantation in patients with ischemic stroke. According to the obtained results, it can be concluded that transplantation of mesenchymal stem cells is safe and feasible from the economic and biomedical point of view. For the further implementa-tion of this promising approach into the clinical practice, randomized, placebo-controlled, multicenter clinical trials are needed with a large sample of patients and optimized cell transplantation protocols and patient inclusion criteria. In this review we also discuss possi-ble strategies to enhance the effectiveness of cell therapy with the use of mesenchymal stem cells.